Strengthening the FDA’s Enforcement of ClinicalTrials.gov Reporting Requirements

JAMA
December 7, 2021, Vol 326, No. 21, Pages 2105-2223
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Strengthening the FDA’s Enforcement of ClinicalTrials.gov Reporting Requirements
Reshma Ramachandran, MD, MPP; Christopher J. Morten, JD, PhD; Joseph S. Ross, MD, MHS
free access
JAMA. 2021;326(21):2131-2132. doi:10.1001/jama.2021.19773
This Viewpoint discusses ways in which the FDA could harness its enforcement tools to bring important missing clinical trial results information to light and demonstrate its commitment to protecting patients through clinical trial transparency.